Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Uni-Charm Indonesia Tbk (UCID.JK)
Jakarta Selatan, ID
PT Uni-Charm Indonesia Tbk plays a significant role in Indonesia's personal hygiene sector. Its operations are organized into two main divisions: Diapers and Non-Diapers. The company is responsible for the production and distribution of various personal care items, including sanitary pads (such as night wings and panty liners) and infant diapers. Additionally, it provides non-woven and tissue paper products, alongside offering a range of trading services. Established in 1997, the firm is headquartered in Jakarta Selatan, Indonesia, and operates as a subsidiary of Unicharm Corporation.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.51% | +4.21% | -1.49% | -12.00% | -7.48% | -7.04% | -28.65% | -64.00% | -75.02% | -77.63% | -77.63% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-17.5% Q1'26: -7.8% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-441.1% Q1'26: +140.0% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-6.5% Q1'26: +3.8% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%-6.9% Q1'26: +3.8% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%-19.5% Q1'26: +7.7% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×-2.53× Q1'26: 0.35× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|
| Revenue |
8.43T
est: 8.52T (-1.0%)
|
9.12T
est: 9.43T (-3.4%)
|
10.32T
est: 9.20T (+12.1%)
|
10.25T
est: 9.96T (+2.9%)
|
9.68T
est: 10.82T (-10.5%)
|
| EBITDA |
951.43B
est: 834.65B (+14.0%)
|
1.11T
est: 923.98B (+20.7%)
|
940.26B
est: 901.15B (+4.3%)
|
1.08T
est: 975.60B (+10.8%)
|
561.77B
est: 798.65B (-29.7%)
|
| EBIT |
515.71B
est: 483.82B (+6.6%)
|
648.21B
est: 535.60B (+21.0%)
|
454.57B
est: 522.37B (-13.0%)
|
594.56B
est: 565.52B (+5.1%)
|
479.46B
est: 332.59B (+44.2%)
|
| Net Income |
311.45B
est: 290.96B (+7.0%)
|
479.74B
est: 399.03B (+20.2%)
|
313.46B
est: 547.25B (-42.7%)
|
434.57B
est: 660.85B (-34.2%)
|
350.41B
est: 791.99B (-55.8%)
|
| SGA |
916.24B
est: 950.08B (-3.6%)
|
928.11B
est: 1.05T (-11.8%)
|
1.14T
est: 1.03T (+10.9%)
|
1.17T
est: 1.11T (+5.5%)
|
1.18T
est: 1.41T (-15.8%)
|
| EPS |
75.05
est: 70.00 (+7.2%)
|
115.79
est: 96.00 (+20.6%)
|
75.65
est: 131.66 (-42.5%)
|
104.89
est: 158.99 (-34.0%)
|
84.30
est: 190.54 (-55.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-26 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-25 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-21 | B | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-20 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-15 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aukaria Rahman | General Manager of HRGA | — | — |
| Ery Suprihardani | Head of Internal Audit | — | — |
| Marojahan Silaen | Legal & Corporate Secretary | — | — |
| Yasutaka Nishioka | President Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for UCID.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
